ADA and pulmonary tuberculosis: Compared to previously studied or emerging biomarkers in pulmonary tuberculosis—such as lymphokine panels or serum proteomic profiles used primarily to differentiate active disease from latent TB infection, ADA remains a compelling candidate [12,13,14].